Manifold Partners’s Global X Scientific Beta Europe ETF SCID Stock Holding History

Manifold Partners’s Portfolio SCID Stock Details SCID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-11,094	Closed	-$244K	–	9
2018 Q4	$244K	Sell	11,094 -32,500	-75%	-$795K	12.75%	3
2018 Q3	$1.18M	Buy	43,594 +8,000	+22%	+$218K	3.16%	7
2018 Q2	$962K	Buy	+35,594	New	+$997K	2.22%	8

Other funds holding SCID

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Manifold Partners's SCID Position: Q1 2019 in Review

Manifold Partners sold out of Global X Scientific Beta Europe ETF (SCID) in Q1 2019, closing a stake of 11,094 shares — an estimated $244K sold.

Manifold Partners first reported a position in SCID in Q2 2018 and held it in 3 quarters. The position peaked at $1.18M in Q3 2018. 6 funds tracked by Wall St. Rank hold SCID as of Q1 2019.

Manifold Partners reported no remaining Global X Scientific Beta Europe ETF position as of Q1 2019 after selling out during the quarter.
Manifold Partners sold 11,094 Global X Scientific Beta Europe ETF shares in Q1 2019, an estimated $244K.
Manifold Partners first reported a position in Global X Scientific Beta Europe ETF in Q2 2018 and held it in 3 quarters.
Manifold Partners's Global X Scientific Beta Europe ETF position peaked at $1.18M in Q3 2018.
6 funds tracked by Wall St. Rank held Global X Scientific Beta Europe ETF as of Q1 2019.

Based on Manifold Partners's 13F filing for Q1 2019, filed 13 May 2019.